Results 101 to 110 of about 88,694 (296)
Pharmacomicrobiomics is an emerging field due to important microbiome effects on pharmacokinetics and clinical outcomes. However, the application of this knowledge remains limited. Mycophenolic acid (MPA) is the primary active metabolite of the immunosuppressant, mycophenolate mofetil (MMF).
Abdelrahman Saqr+4 more
wiley +1 more source
Roghayeh Samadi,1 Zohreh Ghalavand,1 Reza Mirnejad,2 Bahram Nikmanesh,3 Gita Eslami1 1Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2Molecular Biology Research Center, Systems Biology and ...
Samadi R+4 more
doaj
Systematic Disinfection in the Hospital for the Prevention of MRSA and GMRK Infection
Isao Nagai
openalex +2 more sources
Evaluation of MRSA-Screen, a Simple Anti-PBP 2a Slide Latex Agglutination Kit, for Rapid Detection of Methicillin Resistance in Staphylococcus aureus [PDF]
Matthias Cavassini+4 more
openalex +1 more source
Synthetic Biology‐Based Engineering Living Therapeutics for Antimicrobial Application
This perspective highlights synthetic biology‐driven antibacterial strategies, focusing on three innovative approaches: engineered bacteriophages for precision bacterial targeting, reprogrammed microbes that detect quorum‐sensing signals or metabolites to release antimicrobials, and engineering mammalian cells that recognize pathogen‐associated ...
Shun Huang+4 more
wiley +1 more source
Susana Correia,1–4 Vanessa Silva,1–4 Juan García-Díez,5 Paula Teixeira,6 Kevin Pimenta,1–4 María Teresa Tejedor-Junco,7 Soraia Oliveira,1–4 Gilberto Igrejas,2–4 Patricia Poeta1,4 1Microbiology and ...
Correia S+8 more
doaj
Using celastrol as a case study, this review summarizes various target discovery strategies for natural products, including chemical proteomics, protein microarray, degradation‐based protein profiling, proteome‐wide label‐free approaches, network pharmacology, target‐based drug screening, and indirect strategies.
Yanbei Tu+5 more
wiley +1 more source